Primary dysbetalipoproteinemia: predominance of a specific apoprotein species in triglyceride-rich lipoproteins.
about
The Neurobiology and Age-Related Prevalence of the ε4 Allele of Apolipoprotein E in Alzheimer's Disease Cohorts.LDLR expression and localization are altered in mouse and human cell culture models of Alzheimer's diseaseGenetics of the apolipoprotein-E isoprotein system in man.apoE3[K146N/R147W] acts as a dominant negative apoE form that prevents remnant clearance and inhibits the biogenesis of HDL.Familial dysbetalipoproteinemia associated with apolipoprotein E3-Leiden in an extended multigeneration pedigreeMolecular etiology of a dominant form of type III hyperlipoproteinemia caused by R142C substitution in apoE4Characterization of remnants produced during the metabolism of triglyceride-rich lipoproteins of blood plasma and intestinal lymph in the rat.Roles of apolipoproteins B and E in the cellular binding of very low density lipoproteinsMetabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in patients with familial dysbetalipoproteinemia.Pre-beta-very low density lipoproteins as precursors of beta-very low density lipoproteins. A model for the pathogenesis of familial dysbetalipoproteinemia (type III hyperlipoproteinemia)Type III hyperlipoproteinemia associated with apolipoprotein E phenotype E3/3. Structure and genetics of an apolipoprotein E3 variantHigh receptor binding affinity of lipoproteins in atypical dysbetalipoproteinemia (type III hyperlipoproteinemia)Serum lipoproteins and apolipoproteins in rats with streptozotocin-induced diabetes.Human apolipoprotein E isoprotein subclasses are genetically determined.Cholesterol net transport, esterification, and transfer in human hyperlipidemic plasmaApoprotein composition of very low density lipoproteins of human serumCanine hyperlipoproteinemia and atherosclerosis. Accumulation of lipid by aortic medial cells in vivo and in vitro.Isoprotein specificity in the hepatic uptake of apolipoprotein E and the pathogenesis of familial dysbetalipoproteinemia.Increased prevalence of apolipoprotein E4 in type V hyperlipoproteinemia.Radioimmunoassay studies of human apolipoprotein E.Radioimmunoassay of human arginine-rich apolipoprotein, apoprotein E. Concentration in blood plasma and lipoproteins as affected by apoprotein E-3 deficiency.Isolation and characterization of hepatic Golgi lipoproteins from hypercholesterolemic ratsThe interaction of heparin with an apoprotein of human very low density lipoprotein.Biologically active low density lipoprotein in human peripheral lymph.Control of 3-hydroxy-3-methylglutaryl-CoA reductase activity in cultured human fibroblasts by very low density lipoproteins of subjects with hypertriglyceridemiaRole of apolipoprotein E in the lipolytic conversion of beta-very low density lipoproteins to low density lipoproteins in type III hyperlipoproteinemia.Dysbetalipoproteinaemia: a mixed hyperlipidaemia of remnant lipoproteins due to mutations in apolipoprotein E.An abnormal high density lipoprotein in cholestatic plasma isolated by zonal ultracentrifugation.Lipoprotein of the density 1.006-1.020 in the plasma of patients with type III hyperlipoproteinaemia in the postabsorptive state.Familial hyperlipoproteinemia type III: deficiency of a specific apolipoprotein (apo E-III) in the very-low-density lipoproteins.Electron microscopic characterization of lipoproteins from patients with familial type III hyperlipoproteinaemia.Secretion of cholesterol-rich lipoproteins by perfused livers of hypercholesterolemic rats.Characterization of the serum lipoproteins and their apoproteins in hypercholesterolaemic guinea pigs.Hyperlipoproteinaemia and atherosclerosis in rabbits fed low-level cholesterol and lecithin.Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS.The effect of apoE genotype and sex on ApoE plasma concentration is determined by dietary fat in healthy subjects.The Glia-Neuron Lactate Shuttle and Elevated ROS Promote Lipid Synthesis in Neurons and Lipid Droplet Accumulation in Glia via APOE/D.The atherogenic significance of an elevated plasma triglyceride level.Isolation and partial characterization of apolipoprotein D: a new protein moiety of the human plasma lipoprotein system.
P2860
Q30248596-C378273A-10F1-4BEC-922D-4DF073A93934Q33521909-9EAB91AE-2504-44B5-AD0C-C05E899FA5F0Q33669967-B66F6C2F-7835-4E0E-8BBC-50C4F89CB0DDQ33825134-CA686811-9E83-4029-A4CF-6C440828FE41Q34194380-4C8744FA-A155-4579-8DEE-7882EDCF2F5FQ34395148-078DB4FD-48C0-4004-B74F-C9C327A9D251Q34481321-A3E91B4C-8881-4D84-8C0F-18AEC7BD7B40Q34528739-F9A7581C-6BAD-46D8-B086-DC4FCED98EA8Q34538275-B4249CED-F991-4F6D-BFEB-24F440876196Q34560246-EE7DE4A3-8FA4-463A-9419-F143C9FAD771Q34569772-D5902DBD-15FC-4BE2-B026-4708FF4C508FQ34581286-0D3E5CE4-BBCB-4214-B940-6C8636BB505BQ35198844-CB4A315E-C869-4E67-B999-88381FA02F12Q35201063-DD8F0021-BD14-41BF-8604-D5B1D3673B4CQ35203780-58F5C1B1-2F9C-4DDA-8782-3F86EBD87F58Q35902081-7EC37840-74B1-411C-A771-4282A0F4D47DQ36076985-2C5717AA-1B81-4007-8CED-12452F6C0F49Q36399400-EB292F22-05B0-4F06-8C27-6C054123F6F9Q37016558-4EB7413D-8251-413F-A713-04AAA92C713EQ37026434-9287CB10-8006-4CA3-B541-7C594911F8F9Q37026784-5F497983-4795-4344-BD1A-F05429E51EC2Q37027888-CF4752D2-1C1F-42F5-AF0B-C67732642606Q37047755-D1BE9203-FE56-4413-80DF-772411B84E13Q37049646-67198D7A-53D8-4F7C-9B2C-CFC95E22B3ACQ37050609-F9B81F7A-E212-4842-92E3-82A38A1AFB41Q37566831-D686F7C7-7CD4-48BA-91F8-086AF84FADA0Q38176982-CC28AC45-6064-4A48-8EE7-4E332D616404Q39918276-F815F2AA-FB2F-44B1-AC95-421CFF98E08BQ39923961-48A2CB4D-D0C5-41D2-804C-1CE5F28CD8A3Q39947676-120E79C7-D2CC-4D3E-BAD2-3B7112433E04Q40007500-645A5113-36F3-4B90-BF13-FDA5D2DE0AD4Q40239048-D1885780-80BF-44EA-B62C-69029A0B3FCEQ42170109-10E42050-78B8-49C7-A9C0-418319F24057Q42434931-4781D088-4EE2-45D1-A6B5-7C79A4A03D55Q43138847-A549EE72-4B30-46C5-B174-0B0D08761504Q46233800-A22B50A0-D1DC-44EC-8A62-4EFF2B83C95CQ46297739-1F41D91D-FB17-4F1F-AF32-9A315ED517DDQ51565747-22436E03-D2DD-4A34-9D20-EA9CA851D800Q53923584-7D3A9BE1-11F0-43BF-9985-01E9DFAFDDDA
P2860
Primary dysbetalipoproteinemia: predominance of a specific apoprotein species in triglyceride-rich lipoproteins.
description
1973 nî lūn-bûn
@nan
1973 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1973 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1973年の論文
@ja
1973年論文
@yue
1973年論文
@zh-hant
1973年論文
@zh-hk
1973年論文
@zh-mo
1973年論文
@zh-tw
1973年论文
@wuu
name
Primary dysbetalipoproteinemia ...... riglyceride-rich lipoproteins.
@ast
Primary dysbetalipoproteinemia ...... riglyceride-rich lipoproteins.
@en
type
label
Primary dysbetalipoproteinemia ...... riglyceride-rich lipoproteins.
@ast
Primary dysbetalipoproteinemia ...... riglyceride-rich lipoproteins.
@en
prefLabel
Primary dysbetalipoproteinemia ...... riglyceride-rich lipoproteins.
@ast
Primary dysbetalipoproteinemia ...... riglyceride-rich lipoproteins.
@en
P2860
P356
P1476
Primary dysbetalipoproteinemia ...... riglyceride-rich lipoproteins.
@en
P2093
P2860
P304
P356
10.1073/PNAS.70.7.2015
P407
P577
1973-07-01T00:00:00Z